Carson Wealth (CWM LLC)’s SPDR S&P Biotech ETF XBI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Sell |
13,179
-3,494
| -21% | -$290K | ﹤0.01% | 1203 |
|
2025
Q1 | $1.35M | Buy |
16,673
+3,616
| +28% | +$293K | 0.01% | 1001 |
|
2024
Q4 | $1.18M | Buy |
13,057
+2,818
| +28% | +$254K | ﹤0.01% | 1001 |
|
2024
Q3 | $1.01M | Buy |
10,239
+1,849
| +22% | +$183K | ﹤0.01% | 1022 |
|
2024
Q2 | $778K | Buy |
8,390
+866
| +12% | +$80.3K | ﹤0.01% | 1026 |
|
2024
Q1 | $714K | Sell |
7,524
-2,559
| -25% | -$243K | ﹤0.01% | 992 |
|
2023
Q4 | $900K | Sell |
10,083
-12,366
| -55% | -$1.1M | ﹤0.01% | 852 |
|
2023
Q3 | $1.64M | Buy |
22,449
+21,284
| +1,827% | +$1.55M | 0.01% | 592 |
|
2023
Q2 | $97K | Sell |
1,165
-48
| -4% | -$4K | ﹤0.01% | 1588 |
|
2023
Q1 | $92K | Buy |
1,213
+2
| +0.2% | +$152 | ﹤0.01% | 1536 |
|
2022
Q4 | $101K | Sell |
1,211
-2,392
| -66% | -$199K | ﹤0.01% | 1374 |
|
2022
Q3 | $286K | Buy |
3,603
+816
| +29% | +$64.8K | ﹤0.01% | 922 |
|
2022
Q2 | $207K | Sell |
2,787
-1,484
| -35% | -$110K | ﹤0.01% | 1035 |
|
2022
Q1 | $384K | Sell |
4,271
-425
| -9% | -$38.2K | ﹤0.01% | 800 |
|
2021
Q4 | $526K | Buy |
+4,696
| New | +$526K | ﹤0.01% | 711 |
|
2021
Q2 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2021
Q1 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2020
Q4 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2020
Q3 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2020
Q2 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2020
Q1 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2019
Q4 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2019
Q3 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2019
Q2 | $597K | Hold |
4,408
| – | – | ﹤0.01% | 644 |
|
2019
Q1 | $597K | Sell |
4,408
-4,428
| -50% | -$600K | ﹤0.01% | 644 |
|
2018
Q4 | $634K | Buy |
8,836
+8,575
| +3,285% | +$615K | 0.02% | 420 |
|
2018
Q3 | $25K | Buy |
+261
| New | +$25K | ﹤0.01% | 906 |
|